ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
DB3
|
89 |
14K |
6 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
89
|
14K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
DB3
|
261 |
63K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
63K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DB3
|
1.3K |
325K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DB3
|
1.3K |
325K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DB3
|
1.3K |
325K |
34 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
34
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DB3
|
1.3K |
325K |
6 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DB3
|
1.3K |
325K |
8 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
DB3
|
66 |
18K |
16 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
18K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
DB3
|
66 |
18K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
18K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
DB3
|
66 |
18K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
18K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
DB3
|
66 |
18K |
9 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
18K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DB3
|
1.3K |
325K |
10 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DB3
|
1.3K |
325K |
9 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Neurodegenerative Indications other than MND/ALS
|
|
DB3
|
9 |
3.6K |
4 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
9
|
3.6K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
DB3
|
126 |
31K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
126
|
31K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Neurodegenerative Indications other than MND/ALS
|
|
DB3
|
9 |
3.6K |
11 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
9
|
3.6K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
DB3
|
317 |
79K |
3 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
317
|
79K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
DB3
|
317 |
79K |
16 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
317
|
79K
|
16
|
|